Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol

Leukemia Research

Volumn 37, Issue 12, 2013, Pages 1632-1635

  Liew, Elena ^a   Thyagu, Santhosh ^a   Atenafu, Eshetu G ^a   Alibhai, Shabbir M H ^b   Brandwein, Joseph M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Acute lymphoblastic leukemia; Chemotherapy; Leukemia; Quality of life

Indexed keywords

VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANADA; CANCER PAIN; CANCER REGRESSION; CANCER SURVIVOR; CLINICAL ARTICLE; CLINICAL PROTOCOL; COGNITION; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; SELF REPORT; SOCIAL STATUS;

EID: 84888130320     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.09.018     Document Type: Article

References (27)

1. Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 1994, 12:608-616.
2. Testa M.A., Simonson D.C. Assessment of quality-of-life outcomes. N Engl J Med 1996, 334:835-840.
3. Efficace F., Kemmler G., Vignetti M., Mandelli F., Molica S., Holzner B. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 2008, 44:1497-1506.
4. Efficace F., Novik A., Vignetti M., Mandelli F., Cleeland C.S. Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here. Haematologica 2007, 92:1596-1598.
5. Brandwein J.M. Treatment of acute lymphoblastic leukemia in adolescents and young adults. Curr Oncol Rep 2011, 13:371-378.
6. Storring J.M., Minden M.D., Kao S., Gupta V., Schuh A.C., Schimmer A.D., et al. Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen. Br J Haematol 2009, 146:76-85.
7. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376.
8. Michelson H., Bolund C., Nilsson B., Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30 - reference values from a large sample of Swedish population. Acta Oncol 2000, 39:477-484.
9. Yellen S.B., Cella D.F., Webster K., Blendowski C., Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997, 13:63-74.
10. Cleeland C.S., Ryan K.M. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994, 23:129-138.
11. McArthur J.H. The reliability and validity of the subjective peripheral neuropathy screen. J Assoc Nurses AIDS Care 1998, 9:84-94.
12. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-613.
13. Thekkumpurath P., Walker J., Butcher I., Hodges L., Kleiboer A., O'Connor M., et al. Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item patient health questionnaire. Cancer 2011, 117:218-227.
14. Kroenke K., Spitzer R.L. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002, 32:509-515.
15. Cella D., Lai J.S., Chang C.H., Peterman A., Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002, 94:528-538.
16. Curt G.A., Breitbart W., Cella D., Groopman J.E., Horning S.J., Itri L.M., et al. Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist 2000, 5:353-360.
17. Schumacher A., Wewers D., Heinecke A., Sauerland C., Koch O.M., van de Loo J., et al. Fatigue as an important aspect of quality of life in patients with acute myeloid leukemia. Leuk Res 2002, 26:355-362.
18. Servaes P., Verhagen C., Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 2002, 38:27-43.
19. Vora A. Management of osteonecrosis in children and young adults with acute lymphoblastic leukaemia. Br J Haematol 2011, 155:549-560.
20. Walker J., Holm Hansen C., Martin P., Sawhney A., Thekkumpurath P., Beale C., et al. Prevalence of depression in adults with cancer: a systematic review. Ann Oncol 2013, 24:895-900.
21. Walker J., Waters R.A., Murray G., Swanson H., Hibberd C.J., Rush R.W., et al. Better off dead: suicidal thoughts in cancer patients. J Clin Oncol 2008, 26:4725-4730.
22. Dantzer R., Meagher M.W., Cleeland C.S. Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol 2012, 9:414-426.
23. Kim H.J., Barsevick A.M., Fang C.Y., Miaskowski C. Common biological pathways underlying the psychoneurological symptom cluster in cancer patients. Cancer Nurs 2012, 35:E1-E20.
24. Kohli R., Xu W., Brandwein J., Minden M.D., Schimmer A., Schuh A.C., et al. Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR. Bone Marrow Transplant 2010, 45:1256-1258.
25. Scott N., Fayers P., Aaronson N., Bottomley A., de Graeff A., Groenvold M., et al. EORTC QLQ-C30 reference values manual 2008, EORTC Quality of Life Study Group Publications, Brussels.
26. Hjermstad M.J., Fayers P.M., Bjordal K., Kaasa S. Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+3). J Clin Oncol 1998, 16:1188-1196.
27. Schwarz R., Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001, 37:1345-1351.